Entasis Therapeutics' Grant

Entasis Therapeutics raised a round of funding on March 30, 2017. Investors include CARB-X.

Entasis Therapeutics (NASDAQ:ETTX) is developing a portfolio of cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. The Company's…

Articles about Entasis Therapeutics' Grant: